Trending News – February 4, 2021

Trending News US

4 February 2021

In this new minisode series, Mindy, Ryan, and Jen discuss a few recent newsworthy items healthcare leaders should be considering. The episode opens with a discussion of the Biden administration’s initial response to the COVID-10 pandemic (00:35), including the pledge to administer 100 million doses in his first 100 days, the invocation of the Defense Production Act, and the establishment of his COVID Response Taskforce. The conversation then moves to analyzing key healthcare hires in the Biden administration (06:47), including the nomination of Xavier Becerra for HHS Secretary, Vivek Murty for Surgeon General, Rochelle Walensky of the CDC, and Janet Woodcock of the FDA. Outside of the political landscape, vaccine development and distribution continues to make headlines (10:52), with more Americans expressing willingness to receive the vaccine, J&J releasing positive trial results, trials starting in juvenile populations, and Merck pulling their vaccine candidates from development. The episode concludes with a discussion of how Biden’s regulatory freeze memo (15:12), could directly counteract some lame-duck Trump decisions, particularly changes to HIPAA privacy rules, the FDA’s authority over medical devices, and prior authorization requirements.

Next Podcast

18 February 2021

Spotlight Trends: Business Model & Partnership Innovation

Listen to podcast

Previous Podcast

21 January 2021

Spotlight Trends: Looking Forward in 2021

Listen to podcast

Listen now

Speed to publication with GenAI: Done the right way

In the last three years, Generative AI (GenAI) has moved from novelty to expectation. Across industries, teams are being asked, whether explicitly or

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Inizio Ignite brings together Research Partnership, Putnam, Vynamic, and STEM.

Thought Leadership

ASH® 2025 roundtable: Turning hematology innovation into real world progress

Insights from ASH® 2025 on hematology innovation, CAR-T, bispecifics, diagnostics, and how connected strategy supports real-world adoption.